Why the study?
Although the safety and efficacy of prophylactic corticosteroids in cardiac surgery have been extensively examined, the principal research trajectories and emerging trends spanning the past 23 years remained to be elucidated.
This bibliometric analysis highlights a 23-year shift in research focus regarding perioperative corticosteroids in cardiac surgery from inflammatory markers to clinical outcomes, emphasizing the need for personalized treatment strategies.
Answers are grounded in this paper and cite their sources.
Does not alter perioperative corticosteroid protocols; leaves open optimal strategies for future targeted trials.
BACKGROUND: The safety and efficacy of prophylactic corticosteroid administration during the perioperative period of cardiac surgery have undergone extensive and comprehensive examination. In this study, we conducted a bibliometric analysis of publications addressing corticosteroid use in the perioperative period of cardiac surgery, aiming to elucidate the principal research trajectories and emerging trends spanning the past 23 years. METHODS: We performed a search in the Web of Science Core Collection for publications related to the application of corticosteroids during the perioperative period of cardiac surgery, spanning from the year 2000 to October 30, 2023. Bibliometric analysis was conducted employing the biblioshiny package in R, VOSviewer, and CiteSpace. RESULTS: We identified 293 eligible publications concerning corticosteroid use during the perioperative period of cardiac surgery. Publication volume increased significantly in 2001 and 2014. Keyword co-occurrence analysis revealed four primary clusters: cardiopulmonary bypass, systemic inflammatory response, methylprednisolone, and dysfunction. Over recent decades, research focus has shifted from examining how prophylactic corticosteroid use attenuates postoperative inflammation to investigating its potential effects on clinical complications following cardiac surgery. CONCLUSIONS: Considerable heterogeneity in inflammatory response phenotypes among individuals may lead to significant differences in the clinical effectiveness of prophylactic corticosteroid interventions. Thus, developing personalized treatment strategies should become a major focus in future research.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: